BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 25743080)

  • 1. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atropine penalization for "rescuing" patching failures.
    Simon JW; Baxi H
    Arch Ophthalmol; 2009 Feb; 127(2):220-1. PubMed ID: 19204246
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.
    Menon V; Shailesh G; Sharma P; Saxena R
    J AAPOS; 2008 Oct; 12(5):493-7. PubMed ID: 18534880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Compliance and patching and atropine amblyopia treatments"--Reply to Letter to the Editor.
    Wang J
    Vision Res; 2015 Oct; 115(Pt A):153-4. PubMed ID: 26277264
    [No Abstract]   [Full Text] [Related]  

  • 5. Concerning manuscript "Compliance and patching and atropine amblyopia treatments" by Jingyun Wang.
    Loudon SE; Tjiam AM; Simonsz HJ
    Vision Res; 2015 Oct; 115(Pt A):151-2. PubMed ID: 26319949
    [No Abstract]   [Full Text] [Related]  

  • 6. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
    Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
    JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.
    Pediatric Eye Disease Investigator Group.
    Arch Ophthalmol; 2002 Mar; 120(3):268-78. PubMed ID: 11879129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
    Scheiman MM; Hertle RW; Kraker RT; Beck RW; Birch EE; Felius J; Holmes JM; Kundart J; Morrison DG; Repka MX; Tamkins SM;
    Arch Ophthalmol; 2008 Dec; 126(12):1634-42. PubMed ID: 19064841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Combined Occlusion and Atropine Therapy" Versus "Augmented Part-Time Patching" in Children with Refractory/Residual Amblyopia: A Pilot Study.
    Sachdeva V; Mittal V; Gupta V; Gunturu R; Kekunnaya R; Chandrasekharan A; Chabblani PP; Rao HL
    Middle East Afr J Ophthalmol; 2016; 23(2):201-7. PubMed ID: 27162453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
    Repka MX; Wallace DK; Beck RW; Kraker RT; Birch EE; Cotter SA; Donahue S; Everett DF; Hertle RW; Holmes JM; Quinn GE; Scheiman MM; Weakley DR;
    Arch Ophthalmol; 2005 Feb; 123(2):149-57. PubMed ID: 15710809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
    Pediatric Eye Disease Investigator Group
    Ophthalmology; 2003 Aug; 110(8):1632-7; discussion 1637-8. PubMed ID: 12917184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial to evaluate combined patching and atropine for residual amblyopia.
    ; Wallace DK; Kraker RT; Beck RW; Cotter SA; Davis PL; Holmes JM; Repka MX; Suh DW
    Arch Ophthalmol; 2011 Jul; 129(7):960-2. PubMed ID: 21746992
    [No Abstract]   [Full Text] [Related]  

  • 13. PEDIG study on amblyopia; vision therapy by atropine penalization versus occlusion.
    Kowal L
    Binocul Vis Strabismus Q; 2002; 17(4):275. PubMed ID: 12470288
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.
    ; Repka MX; Kraker RT; Beck RW; Holmes JM; Cotter SA; Birch EE; Astle WF; Chandler DL; Felius J; Arnold RW; Tien DR; Glaser SR
    Arch Ophthalmol; 2008 Aug; 126(8):1039-44. PubMed ID: 18695096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amblyopia treatment and quality of life: the child's perspective on atropine versus patching.
    Steel DA; Codina CJ; Arblaster GE
    Strabismus; 2019 Sep; 27(3):156-164. PubMed ID: 31329017
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study.
    Holmes JM; Beck RW; Kraker RT; Cole SR; Repka MX; Birch EE; Felius J; Christiansen SP; Coats DK; Kulp MT;
    Arch Ophthalmol; 2003 Nov; 121(11):1625-32. PubMed ID: 14609923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study.
    Pediatric Eye Disease Investigator Group
    Am J Ophthalmol; 2003 Oct; 136(4):620-9. PubMed ID: 14516801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contradictions in the amblyopia treatment studies.
    Lempert P
    Arch Ophthalmol; 2006 Feb; 124(2):285; author reply 285-7. PubMed ID: 16476906
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of treatment of amblyopia in children aged 7 to 17 years.
    Scheiman MM; Hertle RW; Beck RW; Edwards AR; Birch E; Cotter SA; Crouch ER; Cruz OA; Davitt BV; Donahue S; Holmes JM; Lyon DW; Repka MX; Sala NA; Silbert DI; Suh DW; Tamkins SM;
    Arch Ophthalmol; 2005 Apr; 123(4):437-47. PubMed ID: 15824215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atropine penalisation versus occlusion as the primary treatment for amblyopia.
    Foley-Nolan A; McCann A; O'Keefe M
    Br J Ophthalmol; 1997 Jan; 81(1):54-7. PubMed ID: 9135409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.